Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering

Rhea-AI Summary

Helix Acquisition Corp. III (NASDAQ: HLXC) priced an upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share, implying gross proceeds of approximately $150 million. The shares begin trading on The Nasdaq Global Market under the ticker HLXC on January 23, 2026, and the company expects to consummate the offering on January 26, 2026.

The sponsor is Helix Holdings III LLC, affiliated with Cormorant Asset Management, with management led by Bihua Chen (CEO and chair) and Caleb Tripp (CFO and COO). Leerink Partners and Oppenheimer & Co. are joint bookrunners. The underwriters have a 45-day option to purchase up to an additional 2,250,000 shares to cover over-allotments.

Positive

• Gross IPO proceeds of approximately $150 million
• Shares listed immediately on Nasdaq (HLXC) on January 23, 2026
• Underwriters include Leerink Partners and Oppenheimer & Co.
• Management includes named CEO Bihua Chen and CFO/COO Caleb Tripp

Negative

• Underwriters' 45-day overallotment option could add 2,250,000 shares (15%)
• Company is a SPAC with no announced business combination target

January 23, 2026

BOSTON, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (the “Company”) announced today that it priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol “HLXC” beginning today. The Company expects the offering to be consummated on January 26, 2026.

The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, is led by Bihua Chen as Chief Executive Officer and Chairperson, and Caleb Tripp as Chief Financial Officer and Chief Operating Officer.

Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 Class A ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: Leerink Partners LLC, Attn: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105, or by email at syndicate@leerink.com; and Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at EquityProspectus@opco.com.

A registration statement relating to these securities became effective on January 22, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and preliminary prospectus for the Company's offering filed with the Securities and Exchange Commission (the “SEC”). Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor and Media Contact

Helix Acquisition Corp. III
Caleb Tripp
Email: caleb@cormorant-asset.com
Telephone: (857) 702-0370

FAQ

What did Helix Acquisition Corp. III (HLXC) price its IPO at on January 23, 2026?

HLXC priced its upsized IPO at $10.00 per share for 15,000,000 Class A shares.

When will the Helix Acquisition Corp. III offering be consummated?

The company expects the offering to be consummated on January 26, 2026.

How much gross capital did HLXC raise from the IPO?

The offering implies gross proceeds of approximately $150 million (15,000,000 shares × $10.00).

Will HLXC have an overallotment option and how large is it?

Yes. Underwriters have a 45-day option to buy up to 2,250,000 additional shares to cover over-allotments.

Who are the underwriters and sponsors for HLXC IPO?

The joint bookrunning managers are Leerink Partners and Oppenheimer & Co.; the sponsor is Helix Holdings III LLC affiliated with Cormorant Asset Management.

What is HLXC's stated focus for its future business combination?

HLXC intends to focus on opportunities in healthcare or healthcare-related industries for its initial business combination.